Escolar Documentos
Profissional Documentos
Cultura Documentos
PYOGENIC
MENINGITIS
PREMILA PALANIANDY
012014100157
OUTLINE
1)Definition
2)Etiology
3)Pathogenesis
4)Clinical Features
DEFINITION
Inflammation of the meninges of te brain
Caused by bacterial infection
Bacterial meningitis
ETIOLOGY
1)Neisseria meningitidis
Gram negative cocci
capsulated
Non motile
Serogruops A,B,C,Y,W135
• 90% of infection
2)Streptococcus pneumoniae
Gram positive
Capsulated
Lanceolate diplococci
3)Haemophilus influenzae Type B
Gram negative bacilli
Capsulated
Six different serotypes(a-f)
Common in children
4)Listeria monocytogenes
Gram positive
Bacillus
Immunocompromised adults
-renal transplant,cancer patients
PATHOGENESIS
1)Mode of transmission
-direct contact
-respiratory droplets from nose
and throat of infected people
Bacteria reach
CNS Brain death
Bacterial
Raised intracranial
multiplication
pressure
Inflammatory
response Cerebral edema
fever rash
confusion
Nausea and vomitting
COMPLICATION
1)Brain abscess
2)Hearing loss
3)Cranial nerve palsies
SUMMARY
1)Pyogenic meningitis:
a)Neisseria meningitidis
b)Streptococcus pneumoniae
c)Haemophilus influenzae Type B
d)Listeria monocytogenes
2)Clinical features
-fever,rash,confusion
3)Complication
-hearing loss,brain abscess
MENINGITIS
PART 2
NURUL SOLEHAH BINTI BAHARUDIN
012014100068
OUTLINES
Viral meningitis
Tuberculous meningitis
Fungal meningitis
Parasitic meningitis
Clinical features
VIRAL MENINGITIS
most common type of meningitis
tends to be less severe, rarely last for more than a week and
most people recover completely
Affects children and adults under age 30
Most infections occur in children under age 5
Enterovirus (Echovirus,
Coxsackievirus, Polio virus)
Herpes simplex virus type 2
Mumps and measles virus
Lymphocytic choriomeningitis
Arbovirus
• Japanese encephalitis virus
• Eastern and Western equine encephalitis
HIV
ROUTES
Enteroviruses - Usually through the oral-fecal route, but also
sometimes through the respiratory route
Arboviruses - Via blood-sucking arthropods, usually
mosquitoes
Lymphocytic choriomeningitis virus - Through contact with
rodents (eg, hamster, rats, mice) or their excreta
ENTEROVIRUS
commonest in children aged 5–14 years, but also occurs in
other age groups.
Echovirus infection
• The commonest cause of enteroviral meningitis.
• The predominant serotypes are 6,9, 11, 19 and 30.
There are annual epidemics in the late summer
presenting as so-called ‘summer flu’, with fever,
sore throat and often headache.
• A proportion of infected individuals develop
meningitis, with or without a preceding or
accompanying sore throat.
ENTEROVIRUS
MENINGITIS
Coxsackievirus meningitis
• caused predominantly by serotypes A9, B4 and B5.
• Type A infections affect all age groups
• Type B disease occurs mainly in infants and pre-school
children.
Enteroviruses can cause a rare, generalized chronic brain
infection in individuals with agammaglobulinaemia.
ENTEROVIRUS
MENINGITIS
Polio virus
• 3 serotypes (1,2,3)
• Pathogenesis
• Enters the body through the alimentary tract
and oropharynx
• followed by a viraemic phase during which the
virus enters the meninges and spinal cord.
• The virus infects and kills anterior horn cells,
leading to lower motor neurone degeneration
HERPES SIMPLEX
TYPE 2
CSF EXAMINATION
PRESUMPTIVE IDENTIFICATION
• GRAM STAINING
• LATEX AGGLUTINATION
• RAPID DIAGNOSTIC TEST
CULTURES
POLYMERASE CHAIN REACTION
SEROLOGIC DIAGNOSTIC
CSF
EVALUATION
NORMAL BACTERIAL VIRAL FUNGAL TUBERCULOUS
CSF EVALUATION
Opening
Pressure
(MmH2O)
50-180 Elevated Normal Variable Variable
0-5 Cells
Leukocyte (Adults /
Count Children) >500 Cells <100 Cells 100-500 Cells 100-500 Cells
(Cells/µl ) Up To 30 Cells
(Newborn)
- 60-70%
Lymphocytes
Predominance Early
- 30%
Of Neutrophils Neutrophils,
Cell Differential Monocytes And Lymphocytes Lymphocytes
(PMN's) Late
Macrophages
Lymphocytes
- 2% Other
Cells
Glucose
40-85 <40 Normal <40 <40
(Mg/dL)
Normal;
Appearance Colorless And Turbid Clear Fibrin Web Fibrin Web
Clear
Gram-negative,
coffee-bean shaped diplococci
STREPTOCOCCUS
PNEUMONIAE
Small, pleomorphic
Gram-negative coccobacilli
CRYPTOCOCCAL
MENINGITIS
• White mucoid
colonies within
48hours
• Cultures often
positive in
immunosuppressed
patients
POLYMERASE CHAIN
REACTION
• Species-specific real-time PCR assays
• PCR detection of N. meningitidis, H. influenzae, and S.
pneumoniae can be achieved by amplification of several
potential gene targets (8, 35, 53, 60). The following assays have
been developed and validated to be used on DNA extracted
from clinical specimens (typically, blood and CSF) and bacterial
isolates.
• Serogroup/serotype-specific real-time PCR assays
• The capsule gene loci of both N. meningitidis and H. influenzae
have areas that are both unique and conserved within each
serogroup (N. meningitidis) or serotype (H. influenzae) thus
providing gene targets for the development or real-time PCR
assays designed to identify each specific serogroup or serotype.
SEROLOGIC
DIAGNOSTIC
AGENT COCCI
GRAM POSITIVE
BACILLI
MYCOBACTERIA
CAUSAL MICROORGANISMS
Gram negative cocci (aerobic)
Pathogen Drug of first choice Alternative drug
Neisseria meningitidis Penicillin G Chloramphenicol,
ceftrxone, cefotaxime
MECHANISM OF ACTION
Bactericidal
• Widely distributed
Eg Co- amoxiclav
Amoxicillin + clavulanic acid
Cross BBB
• 2G : cefuroxime
• 3G : cefotaxime, ceftriaxone
• 4G : cefepime
THIRD GENERATION
CEPHALOSPORINS
• Cefotaxime, ceftriaxone
Spectrum
• Gram positive (↑)
• Gram negative (↑↑↑)
ADVERSE EFFECTS
Hypersensitivity : allergic reaction, rash, rare anaphylactis
RIFAMPIN
MOA : inhibit DNA-dependent RNA polymerase. Blocking
production of RNA
ANTITUBERCULOSIS
AGENTS
First line : isoniazid, rifampin, pyrazinamide
Other : levofloxacin
ANTITUBERCULOSIS
AGENTS
Isoniazid(INH), rifampin, pyrazinamide
RIFAMPIN
bactericidal
Enzyme inhibitor
• Inhibit metabolism phenytoin,
warfarin
Peripheral neuritis
• INH + pyridoxine reduces the risk
CORTICOSTEROIDS
Reduction of inflammatory effects associated
with mycobacterial killing by the antimicrobial
agents.
Dexamethasone-recommended dose is 60-80
mg/day, which may be tapered gradually
during a span of 6 weeks.
PREVENTION
CHEMOPROPHYLAXIS
Meningococcal polysaccharide vaccine(MPSV4)
• Subcutaneous
• One dose
• For traveler to endemic area, microbiologist
• Booster every 5 years
a) Rifampin
b) Ceftriaxone
c)Benzylpenicillin
d) isoniazid
QUESTION AND
ANSWER
Adverse Effect:
• Local irritation: topical application
• Headache, diarrhoea, nausea and vomiting: oral
administration
• Transient renal dysfunction: intravenously with high
doses or dehydrated patient
Zidovudine
O Route: Oral
O Mechanism of action:
O Competitive inhibition of HIV-1 reverse
transcriptase
O Incorporation into growing viral DNA chain causes
premature chain termination due to inhibition of
binding with incoming nucleotide
O Half-life: 1 hour
O Clinical uses: HIV
O Adverse effect:
O Myelosuppresion, macrocytic anemia
O GI intolerance
O Headache, insomnia, anxiety, confusion
ANTIFUNGAL
Amphotericin B
Route: Oral
Half-life: 0.8-1.5 hour
Mechanism of action:
• Increase permeability of trematode and
cestodes cell membrane to calcium, resulting in
paralysis, dislodgement and death
Clinical uses:
• Neurocysticercosis, Taeniasis
• Clonorchiasis
• Schistosomiasis
Adverse effect:
•Rashes, fever
•Nausea and abdominal pain
•Headache, dizziness
•Mental changes, seizures,
intracranial hypertension
SUPPORTIVE
THERAPY
1. Correction of fluid and electrolyte
disturbances
2. Control and maintenance of normal
body temperature
3. Control of convulsions
4. Control of increased intracranial
pressure and cerebral edema
5. Nutritional support
REFERENCES
• Katzung, B. G., Masters, S. B., &
Trevor, A. J. (2012). Basic & clinical
pharmacology. New York: McGraw-
Hill Medical.
• http://emedicine.medscape.com/arti
cle/232915-clinical
• http://www.cdc.gov/meningitis/bacte
rial.html